(1)
Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM.
Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical
significance. Am J Obstet Gynecol 2015; 214: S29–S52.
(2)
Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal
inflammatory response syndrome. Am J Obstet Gynecol 1998; 179: 194–202.
(3)
Romero R, Gomez R, Ghezzi F, et al. A fetal systemic inflammatory response
is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;
179: 186–193.
(4)
Gotsch F, Romero R, Kusanovic JP, et al. The fetal inflammatory response
syndrome. Clin Obstet Gynecol 2007; 50: 652–683.
(5)
Mastrolia SA, Erez O, Loverro G, et al. Ultrasonographic approach to
diagnosis of fetal inflammatory response syndrome: a tool for at-risk fetuses? Am J
Obstet Gynecol 2016; 215: 9–20.
(6)
Kidokoro K, Furuhashi M, Kuno N, Ishikawa K. Amniotic fluid elastase and
lactate dehydrogenase: association with histologic chorioamnionitis. Acta Obstet
Gynecol 2006; 85: 669–674.
(7)
Harirah H, Donia SE, Hsu CD. Amniotic fluid matrix metalloproteinase-9 and
interleukin-6 in predicting intra-amniotic infection. Obstet Gynecol 2002; 99: 80–84.
(8)
Yoon BH, Romero R, Moon JB, et al. Clinical significance of intra-amniotic
inflammation in patients with preterm labor and intact membranes. Am J Obstet
Gynecol 2001; 185: 1130–1136.
17
(9)
Asada T, Isshiki R, Hayase N, et al. Impact of clinical context on acute kidney
injury biomarker performances: differences between neutrophil gelatinase-associated
lipocalin and L-type fatty acid-binding protein. Sci Rep 2016; 6: 33077.
(10)
Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for
medical statistics. Bone Marrow Transplant 2013; 48: 452–458.
(11)
Kjeldsen L, Johnsen A.H, Sengelov H, Borregaard N. Isolation and primary
structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol
Chem 1993; 268: 10425–10432.
(12)
Cowland JB, Borregaard N. Molecular characterization and pattern of tissue
expression of the gene for neutrophil gelatinase-associated lipocalin from humans.
Genomics 1997; 45: 17–23.
(13)
Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of
lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.
J Clin Invest 2005; 115: 610–621.
(14)
Mårtensson J, Bellomo R. The rise and fall of NGAL in acute kidney injury.
Blood Purif 2014; 37: 304–310.
(15)
Yoon BH, Park CW, Chaiworapongsa T. Intrauterine infection and the
development of cerebral palsy. BJOG 2003; 110: 124–127.
(16)
Musilova I, Bestvina T, Hudeckova M, et al. Vaginal fluid interleukin-6
concentrations as a point-of-care test is of value in women with preterm prelabor
rupture of membranes. Am J Obstet Gynecol 2016; 215: 619.e1–619.e12.
(17)
Yamamoto T, Noiri E, Ono Y, et al. Renal L-type fatty acid–binding protein in
acute ischemic injury. J Am Soc Nephrol 2007; 18: 2894–2902.
18
(18)
Derikx JP, Poeze M, van Bijnen AA, Buurman WA, Heineman E. Evidence
for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock 2007; 28:
544–548.
(19)
Schurink M, Scholten IG, Kooi EM, et al. Intestinal fatty acid-binding protein
in neonates with imminent necrotizing enterocolitis. Neonatology 2014; 106: 49–54.
(20)
Lencki SG, Maciulla MB, Eglinton GS. Maternal and umbilical cord serum
interleukin levels in preterm labor with clinical chorioamnionitis. Am J Obstet Gynecol
1994; 170: 1345–1351.
(21)
Narendran V, Wickett RR, Pickens WL, Hoath SB. Interaction between
pulmonary surfactant and vernix: a potential mechanism for induction of amniotic fluid
turbidity. Pediatr Res 2000; 48: 120–124.
(22)
Nowak M, Oszukowski P, Szpakowski M, Malinowski A,
Maciolek-Blewniewska G. Intrauterine infections. I. The role of C-reactive protein,
white blood cell count and erythrocyte sedimentation rate in pregnant women in the
detection of intrauterine infection after preliminary rupture of membranes. Ginekol Pol
1998; 69: 615–622.
(23)
Torloni MR, Betrán AP, Horta BL, et al. Prepregnancy BMI and the risk of
gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev
2009; 10: 194–203.
(24)
Li YX, Long DL, Liu J, et al. Gestational diabetes mellitus in women
increased the risk of neonatal infection via inflammation and autophagy in the placenta.
Medicine (Baltimore) 2020; 99: e22152.
19
(25)
Shynlova O, Lee YH, Srikhajon K, Lye SJ. Physiologic uterine inflammation
and labor onset integration of endocrine and mechanical signals. Reprod Sci 2013; 20:
154–167.
20
Tables
Table 1. Patient characteristics and clinical outcomes of the FIRS and non-FIRS groups
Characteristics
FIRS
Non-FIRS
p-value
Patients
36
93
N/A
Age (years)a
33
34
0.654
(22–45)
(18–47)
22.5
44.1
(20/36)
(41/93)
54.7
17.2
(11/36)
(16/93)
22.8
20.9
(16.4–43.9)
(15.2–38.6)
22.2
6.5
(8/36)
(6/93)
16.7
10.8
(6/36)
(10/93)
1.1
(0/36)
(1/93)
2.8
1.1
(1/36)
(1/93)
36.1
34.4
(13/36)
(32/93)
61.1
47.3
(22/36)
(44/93)
Primipara (%)b
IVF (%)b
BMI (kg/m2)a
GDM (%)b
HDP (%)b
Maternal fever (%)b
Fetal tachycardia (%)b
Spontaneous labor onset (%)b
CS (%)b
0.326
0.146
0.047
0.022
0.38
0.482
0.84
0.175
21
GA at delivery (weeks)a
Birth weight (g)a
Umbilical artery pHa
NICU admission (%)b
Neonatal jaundice (%)b
TTN (%)b
RDS (%)b
Respiratory support (%)b
IVH (%)b
ROP (%)b
38.4
38.3
(28.7–40.7)
(30.4–41.4)
3006
2854
(1360–3768)
(1324–3594)
7.302
7.302
(7.016–7.386)
(7.109–7.412)
27.8
26.9
(10/36)
(25/93)
13.9
9.7
(5/36)
(9/93)
8.3
11.8
(3/36)
(11/93)
2.8
1.1
(1/36)
(1/93)
16.7
12.9
(6/36)
(12/93)
2.3
(1/36)
(0/93)
2.3
(1/36)
(0/93)
The Mann–Whitney U-test was used for between-group comparisons, which are
presented as median (range).
0.282
0.343
0.795
0.533
0.756
0.482
0.58
0.279
0.279
22
Fisher’s exact test was used for between-group comparisons.†
FIRS, fetal inflammatory response syndrome; BMI, body mass index; GDM, gestational diabetes
mellitus; IVF, in vitro fertilization; CS, cesarean section; GA, gestational age; NICU, neonatal intensive
care unit; TTN, transient tachypnea of the newborn; RDS, respiratory distress syndrome; IVH,
intraventricular hemorrhage; ROP, retinopathy of prematurity.
23
Table 2. Maternal WBC and CRP levels and amniotic fluid IL-6, NGAL and L-FABP
levels in the FIRS and non-FIRS groups on univariate analysis
Data comparison
WBC (/μL)a
CRP (mg/dL)a
IL-6 (pg/mL)
NGAL
Total
(ng/mL)a
VD
CS
L-FABP (ng/ml)a
FIRS
Non-FIRS
(n=36)
(n=93)
9600
7950
(5200-22900)
(4600-19000)
0.22
0.23
(0.04–7.27)
(0.05–3.21)
22022
2282
(900.5–225145)
(627.3–77969)
581.5
244.5
(113–14700)
(65.0–3090)
1180
529.0
(230–14700)
(170–3090)
156.0
123.5
(113–5610)
(65.0–330)
2.58
2.05
(0.79–91.6)
(0.42–20.8)
p-value
0.008
0.773
<0.001
0.001
<0.001
0.006
0.232
The Mann–Whitney U test was used to compare the data between the groups, presented
as median (range).‡
WBC, white blood cell; CRP, C-reactive protein; IL, interleukin; NGAL, neutrophil
gelatinase-associated lipocalin; L-FABP, L-type fatty acid-binding protein; FIRS, fetal inflammatory
response syndrome; VD, vaginal delivery; CS, cesarean section.
24
Table 3. Maternal WBC level and amniotic fluid IL-6 and NGAL levels on multivariate
logistic regression analysis§
Data comparison
OR (95% CI)
p-value
WBC
4.02 (1.33–12.1)
0.013
IL-6
10.9 (3.41–35.0)
<0.001
NGAL
9.33 (2.86–30.4)
<0.001
§ WBC, white blood cell; IL, interleukin; NGAL, neutrophil gelatinase-associated lipocalin; OR, odds
ratio; CI, confidence interval.
25
Table 4. The relationship between amniotic fluid L-FABP levels and neonatal clinical
outcomes
Data comparison
L-FABP
p-value
control
CS (%)a
50.8
2.13
1.96
(61/120)
(0.42-24.7)
(0.57-17.3)
NICU admission
28.3
2.05
1.98
(%)a
(34/120)
(0.90-24.7)
(0.42-9.17)
Neonatal jaundice
10.8
2.69
1.97
(%)a
(13/120)
(1.06-17.3)
(0.42-24.7)
TTN (%)a
11.6
3.18
1.95
(14/120)
(1.06-24.7)
(0.42-13.9)
1.6
5.19
1.97
(2/120)
(4.07-6.31)
(0.42-24.7)
Respiratory support
14.1
4.57
1.94
(%)a
(17/120)
(0.90-24.7)
(0.42-9.17)
IVH (%)a
0.8
4.57
1.98
(1/120)
(4.57-4.57)
(0.42-24.7)
0.8
4.96
1.98
(1/120)
(4.96-4.96)
(0.42-24.7)
RDS (%)a
ROP (%)a
0.258
0.07
0.09
0.018
0.066
<0.001
0.237
0.194
26
The Mann–Whitney U-test was used for between-group comparisons, which are
presented as median (range).¶
L-FABP, L-type fatty acid-binding protein; CS, cesarean section; NICU, neonatal intensive care unit;
TTN, transient tachypnea of the newborn; RDS, respiratory distress syndrome; IVH, intraventricular
hemorrhage; ROP, retinopathy of prematurity.
27
Table 5. Maternal WBC and CRP levels and amniotic fluid IL-6, NGAL and L-FABP
levels in the spontaneous labor onset and control groups on univariate analysis
Data comparison
Spontaneous
Control
labor onset
(n=82)
p-value
(n=47)
WBC (/μL)a
CRP (mg/dL)a
IL-6 (pg/mL)a
NGAL
Total
(ng/mL)a
VD
CS
L-FABP (ng/ml)a
8700
7800
(5400-22900)
(4600-21700)
0.26
0.22
(0.05–3.21)
(0.04–7.27)
8738.4
2096.9
(737.4–225145)
(627.3–199347)
565
172.5
(142–14700)
(65.0–5610)
618
477
(170–14700)
(188–5610)
218
139
(142–3010)
(65.0–5610)
1.97
2.34
(0.79–17.3)
(0.42–91.6)
0.209
0.846
0.002
<0.001
0.411
0.013
0.512
The Mann–Whitney U-test was used for between-group comparisons, which are
presented as median (range).i
WBC, white blood cell; CRP, C-reactive protein; IL, interleukin; NGAL, neutrophil
gelatinase-associated lipocalin; L-FABP, L-type fatty acid-binding protein; FIRS, fetal inflammatory
response syndrome; VD, vaginal delivery; CS, cesarean section.
...